Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Anticholinergic and sedative medicines - prescribing considerations for people with dementia.

Bell JS, Mezrani C, Blacker N, LeBlanc T, Frank O, Alderman CP, Rossi S, Rowett D, Shute R.

Aust Fam Physician. 2012 Jan-Feb;41(1-2):45-9. Review.

2.

Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia.

Bhattacharya R, Chatterjee S, Carnahan RM, Aparasu RR.

Am J Geriatr Pharmacother. 2011 Dec;9(6):434-41. doi: 10.1016/j.amjopharm.2011.10.001. Epub 2011 Oct 26.

PMID:
22030114
3.

Neurocognitive costs and benefits of psychotropic medications in older adults.

Brooks JO, Hoblyn JC.

J Geriatr Psychiatry Neurol. 2007 Dec;20(4):199-214.

PMID:
18004007
4.

[Drug-induced cognitive impairment].

Shinohara M, Yamada M.

Brain Nerve. 2012 Dec;64(12):1405-10. Review. Japanese.

PMID:
23209067
5.

A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs.

Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA.

Arch Intern Med. 2005 Apr 11;165(7):808-13.

PMID:
15824303
6.

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.

Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K.

BMJ. 2006 Feb 25;332(7539):455-9. Epub 2006 Feb 1.

7.

[Cognition disorders related to psychotropic treatments].

Bazin N.

Rev Prat. 1994 Nov 1;44(17):2332-5. French.

PMID:
7984942
8.

Effects of drug burden index on cognitive function in older men.

Gnjidic D, Le Couteur DG, Naganathan V, Cumming RG, Creasey H, Waite LM, Sharma A, Blyth FM, Hilmer SN.

J Clin Psychopharmacol. 2012 Apr;32(2):273-7. doi: 10.1097/JCP.0b013e3182487825.

PMID:
22367653
9.

Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia.

Cross AJ, George J, Woodward MC, Ames D, Brodaty H, Ilomäki J, Elliott RA.

Drugs Aging. 2016 Jan;33(1):37-44. doi: 10.1007/s40266-015-0332-3.

PMID:
26645294
10.

Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women.

Cao YJ, Mager DE, Simonsick EM, Hilmer SN, Ling SM, Windham BG, Crentsil V, Yasar S, Fried LP, Abernethy DR.

Clin Pharmacol Ther. 2008 Mar;83(3):422-9. Epub 2007 Aug 22.

PMID:
17713474
11.

Drug-induced cognitive impairment in the elderly.

Moore AR, O'Keeffe ST.

Drugs Aging. 1999 Jul;15(1):15-28. Review.

PMID:
10459729
12.

Changes in utilisation of anticholinergic drugs after initiation of cholinesterase inhibitors.

Robinson M, Rowett D, Leverton A, Mabbott V.

Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):659-64. doi: 10.1002/pds.1739.

PMID:
19548222
13.

[Drug-induced Cognitive Impairment].

Shinohara M, Yamada M.

Brain Nerve. 2016 Apr;68(4):421-8. doi: 10.11477/mf.1416200415. Review. Japanese.

PMID:
27056860
14.

[Effect of anticholinergic drugs on cognitive impairment in the elderly].

López-Álvarez J, Zea Sevilla MA, Agüera Ortiz L, Fernández Blázquez MÁ, Valentí Soler M, Martínez-Martín P.

Rev Psiquiatr Salud Ment. 2015 Jan-Mar;8(1):35-43. doi: 10.1016/j.rpsm.2013.11.003. Epub 2014 Jul 30. Review. Spanish.

15.

Temporary cognitive impairment related to administration of newly developed anticholinergic medicines for overactive bladder: two case reports.

Shiota T, Torimoto K, Momose H, Nakamuro T, Mochizuki H, Kumamoto H, Hirayama A, Fujimoto K.

BMC Res Notes. 2014 Sep 25;7:672. doi: 10.1186/1756-0500-7-672.

16.

Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study.

Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE.

J Am Geriatr Soc. 2009 Mar;57(3):427-31. doi: 10.1111/j.1532-5415.2008.02129.x.

PMID:
19278396
17.

Drug Burden Index in older adults: theoretical and practical issues.

Kouladjian L, Gnjidic D, Chen TF, Mangoni AA, Hilmer SN.

Clin Interv Aging. 2014 Sep 9;9:1503-15. doi: 10.2147/CIA.S66660. eCollection 2014. Review.

18.

The cognitive impact of anticholinergics: a clinical review.

Campbell N, Boustani M, Limbil T, Ott C, Fox C, Maidment I, Schubert CC, Munger S, Fick D, Miller D, Gulati R.

Clin Interv Aging. 2009;4:225-33. Epub 2009 Jun 9. Review.

19.

Adverse effects of anticholinergic activity on cognitive functions in Alzheimer's disease.

Konishi K, Hori K, Uchida H, Watanabe K, Tominaga I, Kimura M, Hosoyamada M, Shibasaki T, Kataoka A, Hachisu M.

Psychogeriatrics. 2010 Mar;10(1):34-8. doi: 10.1111/j.1479-8301.2010.00310.x.

20.

A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people.

Gnjidic D, Le Couteur DG, Abernethy DR, Hilmer SN.

Ann Pharmacother. 2010 Nov;44(11):1725-32. doi: 10.1345/aph.1P310. Epub 2010 Sep 28.

PMID:
20876826
Items per page

Supplemental Content

Write to the Help Desk